Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
•August 7, 2024
0
The AI Podcast (NVIDIA)•Aug 7, 2024
Why It Matters
He highlights concrete examples of AI‑driven pipelines that have accelerated candidate selection and reduced development timelines, illustrating a broader industry shift toward data‑centric, scalable research.
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
Comments
Want to join the conversation?
Loading comments...